Cannabidiol News and Research

Latest Cannabidiol News and Research

Online cannabis oils contain dangerous amounts of psychoactive THC

Scientists have published a review in the BMJ which calls for more research and regulations surrounding CBD oils offered by online sellers, after it was found that most contain the psychoactive ingredient THC.

8 Apr 2019

Clinical trial examines medicinal cannabis as potential treatment for severe Tourette syndrome

A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with severe Tourette syndrome will be conducted by Wesley Medical Research, in Brisbane in Australia, with cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at University of Sydney.

28 Mar 2019

People with and without cancer use different dosages of cannabis formulations, study shows

People with and without cancer are more likely, over time, to use a more potent form of medical marijuana with increasingly higher amounts of tetrahydrocannabinol, a new study shows.

26 Mar 2019

Daily marijuana use may increase risk of psychosis

People who use marijuana on a daily basis may be at an increased risk of developing psychosis, particularly if it is high-potency, experts warn.

25 Mar 2019

Researchers solve major gap in scientific literature with mobile software technology

Researchers at the University of New Mexico recently solved a major gap in scientific literature by using mobile software technology to measure the real-time effects of actual cannabis-based products used by millions of people every day.

27 Feb 2019

Canbiola announces launch of revolutionary Sustained Acoustic Medicine wellness solution

Canbiola, Inc. a developer, manufacturer and seller of a variety of Cannabidiol based products such as oils, creams, moisturizers, chews, isolate, gel caps, concentrate and water, announced today the launch and availability of a revolutionary Sustained Acoustic Medicine wellness solution.

31 Jan 2019

Medical cannabis relieves ASD symptoms in children

In a new study of patients with autism who are 18 years old and under, researchers from Ben-Gurion University of the Negev and Soroka University Medical Center report that cannabis as a treatment for autism spectrum disorders appears to be a well-tolerated, safe and effective option to relieve symptoms including seizures, tics, depression, restlessness, and rage attacks.

31 Jan 2019

Highly effective protocol to prepare cannabis samples for THC/CBD analysis

Porvair Sciences describes how to use its Plant Genomics microplate for preparing cannabis samples for analysis of Tetrahydrocannabinol and Cannabidiol.

From Porvair Sciences Limited 17 Jan 2019

Study reveals increase in potency and price of cannabis across Europe

Cannabis resin and herbal cannabis have significantly increased in potency and in price, according to the first study to investigate changes in cannabis across Europe.

2 Jan 2019

Study: Cannabidiol may worsen glaucoma, increase eye pressure

One of the most commonly proposed uses of medical marijuana is to treat glaucoma.

18 Dec 2018

London-based startup launches 'thedrug.store' aiming to clean up CBD industry

"thedrug.store" is an online Cannabidiol (CBD) retailer launched by a London-based startup, providing a selection of quality brands to meet the growing demand for CBD products in the UK and mainland Europe.

12 Dec 2018

Cannabis-based compound shows promise to reduce seizures in children with epilepsy

Interest has been growing in the use of cannabinoids--the active chemicals in cannabis or marijuana-- for the treatment of epilepsy in children. A recent Epilepsia analysis of relevant published studies indicates that this strategy looks promising.

5 Dec 2018

Cannabinoids hold promise in treating children with epilepsy

In recent years, cannabinoids--the active chemicals in medical marijuana-- have been increasingly touted as a potential treatment for a range of neurological and psychiatric disorders. In a Developmental Medicine & Child Neurology review, investigators compare their efficacy with antiepileptic drugs for children with epilepsy.

7 Nov 2018

Effective dose of cannabidiol for safe pain relief without the typical 'high'

In the wake of cannabis legalization, a team of scientists at the Research Institute of the McGill University Health Center and McGill University have delivered encouraging news for chronic pain sufferers by pinpointing the effective dose of marijuana plant extract cannabidiol for safe pain relief without the typical "high" or euphoria produced by the THC.

25 Oct 2018

Cannabis oil shown to significantly improve Crohn’s disease symptoms

In the first study of its kind, cannabis oil has been shown to significantly improve the symptoms of Crohn’s disease and the quality of life of sufferers but, contrary to previous medical thinking, has no effect on gut inflammation.

23 Oct 2018

Cannabinoid drugs reduce perceived unpleasantness of painful stimuli and increase tolerance

Researchers in the College of Arts and Sciences have determined that cannabinoid drugs do not appear to reduce the intensity of experimental pain, but, instead, may make pain feel less unpleasant and more tolerable.

19 Sep 2018

Novel clinical trial to examine cannabis as potential treatment for essential tremor

Researchers at University of California School of Medicine are preparing to launch a novel clinical trial to examine the safety, efficacy and pharmacological properties of cannabis as a potential treatment for adults with essential tremor.

18 Sep 2018

Day-tripping to the dispensary: Seniors in pain hop aboard the canna-bus

Shirley Avedon, 90, had never been a cannabis user. But carpal tunnel syndrome that sends shooting pains into both of her hands and an aversion to conventional steroid and surgical treatments is prompting her to consider some new options.

18 Sep 2018

Medical marijuana may alter brain connections to provide relief from chronic nerve pain

When medical marijuana is taken for chronic nerve pain, it may provide pain relief by reducing connections between the areas of the brain that process emotions and sensory signals, according to a study published in the September 5, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

6 Sep 2018

Single dose of cannabidiol showed effective results in rats with symptoms of depression

Commercial antidepressants typically take two to four weeks to have a significant effect on a depressed patient. They are also inneffective in approximately 40% of the cases.

31 Aug 2018

Cannabidiol News and Research

Latest Cannabidiol News and Research

Online cannabis oils contain dangerous amounts of psychoactive THC

Clinical trial examines medicinal cannabis as potential treatment for severe Tourette syndrome

People with and without cancer use different dosages of cannabis formulations, study shows

Daily marijuana use may increase risk of psychosis

Researchers solve major gap in scientific literature with mobile software technology

Canbiola announces launch of revolutionary Sustained Acoustic Medicine wellness solution

Medical cannabis relieves ASD symptoms in children

Highly effective protocol to prepare cannabis samples for THC/CBD analysis

Study reveals increase in potency and price of cannabis across Europe

Study: Cannabidiol may worsen glaucoma, increase eye pressure

London-based startup launches 'thedrug.store' aiming to clean up CBD industry

Cannabis-based compound shows promise to reduce seizures in children with epilepsy

Cannabinoids hold promise in treating children with epilepsy

Effective dose of cannabidiol for safe pain relief without the typical 'high'

Cannabis oil shown to significantly improve Crohn’s disease symptoms

Cannabinoid drugs reduce perceived unpleasantness of painful stimuli and increase tolerance

Novel clinical trial to examine cannabis as potential treatment for essential tremor

Day-tripping to the dispensary: Seniors in pain hop aboard the canna-bus

Medical marijuana may alter brain connections to provide relief from chronic nerve pain

Single dose of cannabidiol showed effective results in rats with symptoms of depression

Pittcon Highlights: Cannabis & Psychedelics eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Cannabidiol News and Research

Latest Cannabidiol News and Research

Pittcon Highlights: Cannabis & Psychedelics eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in